In May 2018, the FDA approved the IDE study for the treatment of Meniere’s disease and persistent dizziness. In this study, labyrinthectomy and cochlear implantation can be performed simultaneously in unilateral Meniere's disease, which further supports the determination of speech perception, localization, and the results of quality of life
According to the report, High Prevalence of Meniere’s disease is Driving the Market Growth
is one of the primary growth factors for the market. Rise in Geriatric Population, Environmental Pollution, Noise Pollution
is also expected to contribute significantly to the Meniere’s disease drug market. Overall, Hospitals
applications of Meniere’s disease drug, and the growing awareness of them, is what makes this segment of the industry important to its overall growth. The Drug Type, such as Meclizine, is boosting the Meniere’s disease drug market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The Route of Administration, such as Oral, is boosting the Meniere’s disease drug market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The Distribution Channel, such as Online Pharmacy, is boosting the Meniere’s disease drug market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The Treatment Type, such as Medications, is boosting the Meniere’s disease drug market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The Mechanism, such as Anti-Histamines, is boosting the Meniere’s disease drug market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.
AMAs Analyst on the Global Meniere’s disease drug market identified that the demand is rising in many different parts of the world as "Rising Investment in the Research & Development for the Treatments for This Disease Is Expected To Drive the Market Growth
". Furthermore, some recent industry insights like "In June 2019, Otonomy Inc. developed the drug Otividex for the treatment of Menière's disease, which is in the clinical phase 3 study. In November 2017, Otonomy Inc. announced that the AVERTS-2 study conducted in Europe had met its primary endpoint (p-value = 0.029) and Otividex demonstrated clinically significant treatment benefit for patients" is constantly making the industry dynamic.
The report provides an in-depth analysis and forecast about the industry covering the following key features: o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies o Analyses the Global Meniere’s disease drug market according to Type, Application, and regions o Analyzes the top 10 players in terms of market reach, business strategy, and business focus o Provides stakeholders insights and key drivers & trends of the market
**The market is valued based on weighted average selling price (WASP) and includes any applicable taxes on manufacturers. All currency conversions used in the creation of this report have been calculated using constant annual average 2018 currency rates.
Market Size Estimation In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Meniere’s disease drug market and other related sub-markets covered in the study.
o Key & emerging players in the market have been observed through secondary research. o The industrys supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes. o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation The overall Meniere’s disease drug market size is calculated using market estimation process, the Meniere’s disease drug market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Meniere’s disease drug market size has been validated using both top-down and bottom-up approaches.